Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05055245
Other study ID # 20210914
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 9, 2021
Est. completion date April 9, 2022

Study information

Verified date September 2021
Source Women's Hospital School Of Medicine Zhejiang University
Contact Yimin Zhu, Dr.
Phone 057189992071
Email zhuyim@zju.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

With the development of assisted reproductive technology (ART), more and more infertile women are obtaining their offspring through assisted reproductive technology. However, a growing number of national and international studies have shown that infertility patients are prone to negative emotions such as anxiety and depression during ART treatment, which not only affects their physical and mental health, but also affects the embryo implantation rate and pregnancy rate of ART. The purpose of this study is to investigate the stress faced by participants undergoing ART with different cycles and to further investigate its impact on pregnancy outcomes.


Description:

With the rapid social and economic development in recent years, the incidence of infertility has increased significantly due to environmental pollution, poor lifestyle habits and increasing stress in various areas. According to global statistics, one in six married couples suffers from infertility. With the development of assisted reproductive technology (ART), more and more infertile women are obtaining their offspring. In clinical practice, however, a significant proportion of patients undergoing ART have low embryo implantation and pregnancy rates and experience recurrent implantation failure (RIF). A growing number of national and international studies have shown that infertility patients are prone to negative emotions such as anxiety and depression during ART treatment, which not only affects their physical and mental health, but also affects the embryo implantation rate and pregnancy rate of ART. This effect is more pronounced in patients with multiple failed transfers. In this study, investigators intend to investigate the stress faced by participants undergoing assisted reproduction with different cycles to provide a reliable basis for future psychological interventions and health education for this group of patients and improve the quality of life of infertility patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date April 9, 2022
Est. primary completion date March 9, 2022
Accepts healthy volunteers No
Gender All
Age group 16 Years to 40 Years
Eligibility Inclusion Criteria: - Female partners' >18< 40 years - Patients undergoing assisted reproductive technology Exclusion Criteria: - Female partners with polycystic ovary - Female partners with insufficiency or premature ovarian failure - Female partners with endometriosis - Female partners with abnormal profile of thyroid hormones - Chromosomal abnormalities of either spouse - Mental disorder of either spouse

Study Design


Related Conditions & MeSH terms


Intervention

Other:
cycles
Patients are grouped according to the number of IVF/ICSI cycles.

Locations

Country Name City State
China Women's Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Women's Hospital School Of Medicine Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Implantation rate Implantation rate is defined as number of sacs per embryo transferred. 6 months
Primary clinical pregnancy rate presence of at least one gestational sac on ultrasound of 6 weeks 6 months
Secondary fertilization rate No. of fertilized oocyte divided by No. of inseminated cumulus-oocyte complexes (COCs) 6 months
Secondary cleavage rate No. of cleaved embryo divided by No. of fertilized oocyte 6 months
Secondary Total gonadotropin use Total gonadotropin use of each participant 6 months
Secondary Ovarian hyperstimulation syndrome (OHSS) rates OHSS rates in both study groups 6 months
Secondary Number of oocytes retrieved 6 months
Secondary Metaphase II (MII) oocytes the number of mature oocytes 6 months
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A